177 related articles for article (PubMed ID: 10556824)
1. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection.
Grigoriadou K; Ménard C; Pérarnau B; Lemonnier FA
Eur J Immunol; 1999 Nov; 29(11):3683-90. PubMed ID: 10556824
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
Held W; Cado D; Raulet DH
J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
[TBL] [Abstract][Full Text] [Related]
4. Xenogeneic beta 2-microglobulin substitution alters NK cell function.
Benoît LA; Tan R
J Immunol; 2007 Aug; 179(3):1466-74. PubMed ID: 17641012
[TBL] [Abstract][Full Text] [Related]
5. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
Vallera DA; Taylor PA; Sprent J; Blazar BR
Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
[TBL] [Abstract][Full Text] [Related]
6. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains.
Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
Eur J Immunol; 1998 Jan; 28(1):370-8. PubMed ID: 9485216
[TBL] [Abstract][Full Text] [Related]
7. The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.
Beilke JN; Benjamin J; Lanier LL
Blood; 2010 Dec; 116(24):5208-16. PubMed ID: 20736452
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells.
Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M
Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556
[TBL] [Abstract][Full Text] [Related]
9. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing.
Sun K; Alvarez M; Ames E; Barao I; Chen M; Longo DL; Redelman D; Murphy WJ
Blood; 2012 Feb; 119(6):1590-8. PubMed ID: 22184406
[TBL] [Abstract][Full Text] [Related]
10. Influence of xenogeneic beta2-microglobulin on functional recognition of H-2Kb by the NK cell inhibitory receptor Ly49C.
Benoit LA; Shannon J; Chamberlain JW; Miller RG
J Immunol; 2005 Sep; 175(6):3542-53. PubMed ID: 16148097
[TBL] [Abstract][Full Text] [Related]
11. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
12. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
[TBL] [Abstract][Full Text] [Related]
13. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice.
Smyth MJ; Snook MB
Cell Immunol; 1999 Aug; 196(1):51-9. PubMed ID: 10486155
[TBL] [Abstract][Full Text] [Related]
14. Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.
Sullivan LC; Berry R; Sosnin N; Widjaja JM; Deuss FA; Balaji GR; LaGruta NL; Mirams M; Trapani JA; Rossjohn J; Brooks AG; Andrews DM
J Biol Chem; 2016 Sep; 291(36):18740-52. PubMed ID: 27385590
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
16. Comparative ability of Qdm/Qa-1b, kb, and Db to protect class Ilow cells from NK-mediated lysis in vivo.
Jia SH; Kurepa Z; Bai A; Forman J
J Immunol; 2000 Dec; 165(11):6142-7. PubMed ID: 11086047
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes.
Iizuka K; Scalzo AA; Xian H; Yokoyama WM
J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550
[TBL] [Abstract][Full Text] [Related]
18. Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f.
Sentman CL; Kumar V; Bennett M
Eur J Immunol; 1991 Nov; 21(11):2821-8. PubMed ID: 1718761
[TBL] [Abstract][Full Text] [Related]
19. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
[TBL] [Abstract][Full Text] [Related]
20. Lack of F1 anti-parental resistance in H-2b/d F1 hybrids devoid of beta2-microglobulin.
Höglund P; Olsson-Alheim MY; Johansson M; Kärre K; Sentman CL
Eur J Immunol; 1997 Jan; 27(1):342-5. PubMed ID: 9022038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
